SCHEMBL9943544

SCHEMBL9943544

COc1ccc(Cn2cc3cc(NC(=O)O)ccc3n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.49
SNCA P37840 1/20 0.48
ERBB2 P04626 1/20 0.48
MAPT P10636 6/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CACNA1G O43497 1/20 0.47
CACNA1H O95180 1/20 0.47
CACNA1I Q9P0X4 1/20 0.47
NPC1 O15118 2/20 0.47
TSHR P16473 2/20 0.47
RAB9A P51151 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ATM Q13315 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ADORA3 P0DMS8 1/20 0.46
ADORA2B P29275 1/20 0.46
MCHR1 Q99705 2/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9910661 0.86 HDAC3 (0.46) IRAK4SNCAERBB2MAPTSMN1; SMN2
SCHEMBL7977921 0.82 KDM4E (0.50) SNCASMN1; SMN2CACNA1GCACNA1HCACNA1I
SCHEMBL1645807 0.82 GSK3B (0.46) IRAK4SNCAMAPTCACNA1GCACNA1H
SCHEMBL760076 0.81 CA1 (0.47) SNCASMN1; SMN2CACNA1GCACNA1HCACNA1I
SCHEMBL7977927 0.80 HDAC6 (0.49) SNCACACNA1GCACNA1HCACNA1IL3MBTL1
SCHEMBL1163484 0.78 CACNA1G (0.45) IRAK4SNCAERBB2MAPTCACNA1G
SCHEMBL27750270 0.78 KMT2A (0.46) SNCACACNA1GCACNA1HCACNA1INPC1
SCHEMBL7988907 0.78 THRB (0.50) SNCAMAPTKDM4EL3MBTL1ADORA3
SCHEMBL662061 0.77 IDO1 (0.45) ERBB2MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL17602073 0.76 MAPT (0.54) ERBB2MAPTSMN1; SMN2CACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2464228-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT Merck Sharp & Dohme Corp. (US) 2012-06-20 EP disclosed